Janus Henderson Group PLC
- SEC CIK
- 0001274173
- Latest filing
- May 18, 2026
DAWN holding history
Day One Biopharmaceuticals, Inc. in every 13F filed by Janus Henderson Group PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DAWN overviewAll 13F holders of DAWNFull Q1 2026 holdings
- Shares (Q1 2026)
- 546,428
- Value
- $11.7M
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 546,428 | $11.7M | <0.1% | +525,128+2,465.4% | Added | Holders |
| Q4 2025 | 21,300 | $198.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 21,300 | $150.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 21,300 | $138.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 21,300 | $172.0K | <0.1% | −1,284,920−98.4% | Reduced | Holders |
| Q4 2024 | 1,306,220 | $16.6M | <0.1% | −870,977−40.0% | Reduced | Holders |
| Q3 2024 | 2,177,197 | $30.3M | <0.1% | +337,928+18.4% | Added | Holders |
| Q2 2024 | 1,839,269 | $25.4M | <0.1% | −193,115−9.5% | Reduced | Holders |
| Q1 2024 | 2,032,384 | $33.6M | <0.1% | +336,281+19.8% | Added | Holders |
| Q4 2023 | 1,696,103 | $24.8M | <0.1% | +874,650+106.5% | Added | Holders |
| Q3 2023 | 821,453 | $10.1M | <0.1% | +133,943+19.5% | Added | Holders |
| Q2 2023 | 687,510 | $8.21M | <0.1% | +124,716+22.2% | Added | Holders |
| Q1 2023 | 562,794 | $7.53M | <0.1% | +562,794 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −902,020−100.0% | Sold out | Holders |
| Q1 2022 | 902,020 | $8.95M | <0.1% | −120,528−11.8% | Reduced | Holders |
| Q4 2021 | 1,022,548 | $16.6M | <0.1% | +650.0% | Added | Holders |
| Q3 2021 | 1,022,483 | $23.4M | <0.1% | −275,287−21.2% | Reduced | Holders |
| Q2 2021 | 1,297,770 | $27.9M | <0.1% | +1,297,770 | New | Holders |